Category: Forbes

Tanezumab’s Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments

As the opioid crisis has unfolded concerns have grown about dependency and the potentially addictive nature of opioid-based pain treatments. Having satisfactory non-opioid treatment alternatives will need to be an integral part of effective pain manage…

Why Experts Can’t Fix Pharma’s Innovation Crisis (Part 1) And What to Do About It (Part 2)

Scientific excellence is the foundation of the industry, but the solution to the innovation crisis, if there is one, lies not in technology but a new business model.

That Nonprofit Generic Firm Has A Name, $100 Million, And A CEO Who Will Work For Free

“We don’t think this market should be monetized,” says the chair of the board.

This Is How Disgusting Airport Security Trays Are

A study found that these trays may be carrying more than just your bags, shoes, smartphones, and neck pillows.

HPV Vaccine May Reduce Risk Of Transmitting Devastating Throat Disease To Children

Human papillomavirus (HPV) of the female genital tract may infect the fetus, leading to a rare, yet severe respiratory disease in infants and children. Studies are underway to address the eradication of this disease by widespread use of the HPV vaccine.

Sick Passengers On Flight From Dubai: Key Facts About Illness On Airplanes

Several passengers became acutely ill on a flight from Dubai to New York City. Here’s what you need to know about illnesses while flying.

CDC: Why You Should Not Eat Any Kellogg’s Honey Smacks Cereal

The CDC has just upped its warning about the cereal. So far, the ongoing multi-state Salmonella Mbandaka outbreak has affected at least 130 people in 36 states.

Senate Bill Would Legalize Medical Marijuana For Military Veterans

Military veterans would be able to legally access and use medical cannabis under a new Senate bill.

As Theranos Dissolves, Healthcare Startup Funding Hits Record High

Venture capital funding for healthcare startups this year hit $20 billion in August.

England’s Health Service Does Deal With Novartis To Provide Kymriah For Relapsed Childhood Leukemia

The National Health Service in England will offer CAR T-cell therapy to children with leukemia after striking a discount deal with Novartis.